Ovizio

Ovizio develops digital holographic interferometric microscopy products. It builds 4D microscopic imaging devices and software based on digital holographic microscopy.

Ovizio offers oLine 4D, a research and development, and diagnostic desktop device that is used without specific sample preparation, as well as with automatic compensation of scratches or distortions on the sample support; iLine 4D, a multipurpose device for applications, such as inline or online flow monitoring or direct monitoring of cell cultures in bioreactors; and OsOne software for visualization, analysis, and archiving of images captured by the imaging devices. It also provides ILine F, a device that captures suspension cell culture process in real time; iLine M, an instrument that monitors cell confluence in multi layer vessels; iLine S, an equipment that monitors reproducibility of fragile cell; and QMod, a holographic and fluorescene microscopy.

Scientists in the areas of pharmaceutical and biotech research and development use the products of Ovizio. Philip Mathuis and Serge Jooris founded it in 2009, with its headquarters in Brussels in Belgium.

Ovizio headquartered in Europe, operates in the Software, 3D Technology, Biotechnology, Artificial Intelligence (AI), Life Science, Medical Device sector. The company focuses on Software and has secured $412.8M in funding across 48 round(s). With a team of 11-50 employees, Ovizio is actively contributing to advancements in Software. Their latest funding round, Venture Round - Ovizio, raised $8.5M. Discover more about their projects, partnerships, and impact on our platform.